David Altshuler, EVP, Global Research and CSO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 12,146 shares at $287.23 ($3.5M) on 2023-02-27, disclosed to the SEC on 2023-02-28.
Seasonal sale ($3.5M) by EVP, Global Research and CSO — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $289.12 | 3,970 | $1.1M | 32.8% |
| 2 | $287.23 | 3,636 | $1.0M | 29.9% |
| 3 | $287.23 | 3,636 | $1.0M | 29.9% |
| 4 | $288.74 | 300 | $87K | 2.5% |
| 5 | $289.60 | 302 | $87K | 2.5% |
| 6 | $289.60 | 302 |
| $87K |
| 2.5% |
| Total | $288.00 avg | 12,146 | $3.5M | 100% |
| Filing → |
| VRTX | SELL | 2025-03-12 | $1.6M | — | Filing → |
| VRTX | SELL | 2025-03-05 | $1.6M | — | Filing → |
| VRTX | SELL | 2025-02-28 | $611K | — | Filing → |